For patients with chronic pelvic inflammation or endometrial damage, the peptide could potentially be used as an adjunct to standard of care once safety and efficacy data are available
Given the potential effects on angiogenesis and tissue growth, patients should be monitored for any signs of abnormal tissue proliferation or changes that could indicate malignant transformation
GHK-Cu Injection Site and Injection Sites: Quick Answer For people searching GHK-Cu injection site or GHK-Cu injection sites , the general subcutaneous-site list is abdomen, outer thigh, and upper arm
It is not an FDA-approved drug for systemic therapeutic use
BPC-157: Proposed to treat ulcerative colitis TB-500: Proposed for wound healing KPV: Proposed for wound healing and inflammatory conditions MOTS-c: Proposed to treat obesity and osteoporosis Semax: Proposed to treat cerebral ischemia (a shortage of blood flow and oxygen to the brain), migraine and trigeminal neuralgia (a chronic pain condition in the face) Epitalon: Proposed to treat insomnia While some peptide experts celebrate this as one step closer to access to life-improving drugs, others claim there isnt enough data on safety and efficacy